EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated

Jia-Ping Ruan1, Hong-Xing Zhang, Xian-Fu Lu

  • 1Jiangsu Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, China.

Anesthesiology
|April 17, 2010
PubMed
Abstract

Insights

Mitogen-activated protein kinases (MAPKs) activation contributes to spinal pain signaling involving EphrinB/EphB pathways. Inhibiting MAPKs or EphB receptors alleviates pain behaviors and spinal cord activation.

Area of Science:

  • Neuroscience
  • Pain Research
  • Molecular Biology

Background:

  • EphB receptors and ephrinB ligands modulate spinal nociceptive information.
  • Downstream mechanisms of this modulation are not fully understood.
  • Investigating the role of mitogen-activated protein kinases (MAPKs) in this process.

Purpose of the Study:

  • To investigate the role of MAPKs as downstream effectors in spinal nociceptive information modulation by ephrinB/EphB signaling.
  • To elucidate the mechanisms by which MAPKs influence pain signaling pathways.

Main Methods:

  • Assessed thermal hyperalgesia and mechanical allodynia using radiant heat and von Frey filaments.
  • Utilized immunofluorescence staining to detect p-MAPKs, neuronal nuclei, and glial fibrillary acidic protein.
  • Employed immunohistochemistry for c-Fos expression and Western blot assay for p-MAPKs.
  • Administered intrathecal injections of ephrinB1-Fc, EphB1-Fc, MAPK inhibitors, and MK-801.

Main Results:

  • Intrathecal ephrinB1-Fc induced dose- and time-dependent hyperalgesia, increased spinal p-MAPKs and c-Fos expression.
  • p-MAPKs colocalized with neuronal and astrocyte markers in the spinal cord.
  • MAPK inhibition reversed pain behaviors and c-Fos expression induced by ephrinB1-Fc.
  • EphB receptor inhibition reduced inflammation and neuropathic pain, decreasing spinal p-MAPKs and c-Fos.
  • NMDA receptor antagonist MK-801 prevented ephrinB1-Fc-induced hyperalgesia and spinal MAPK activation.

Conclusions:

  • MAPK activation plays a significant role in modulating spinal nociceptive information mediated by ephrinB/EphB signaling.
  • These findings highlight MAPKs as key players in the downstream signaling pathways of EphB receptors and ephrinB ligands in pain modulation.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Integration of Synaptic Events01:28

Integration of Synaptic Events

Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...